News

Outset Medical Names Business Leader Dale E. Jones to Board of Directors

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of dialysis,…

2 years ago

NanoScientific Symposium 2022 Now Open for Registration

SUWON, South Korea, April 25, 2022 /PRNewswire/ -- The NanoScientific Symposium 2022, an international event that brings together researchers and entrepreneurs…

2 years ago

CENTR Adds More than 350 New Retail Locations in March

Vancouver, British Columbia--(Newsfile Corp. - April 25, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company"),…

2 years ago

Hemostemix Announces Closing of $2,750,000

Calgary, Alberta--(Newsfile Corp. - April 25, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

2 years ago

Fathom Secures Investment From Vituity’s Inflect Health

Fathom is the first medical coding automation company to receive investment from a national physician group SAN FRANCISCO--(BUSINESS WIRE)--#AIsolution--Fathom, the…

2 years ago

Menlo Micro’s Ideal Switch Wins Edison Award for Accelerating the Electrification of Everything

Groundbreaking Switch Technology Recognized in the Energy Grid and Power Supply Category as the Most Important Electronic Component Innovation Since…

2 years ago

Cloud DX to Present at ONE2ONE Investors Forum

Cloud DX selected as a leading growth company and investment opportunity for the Proactive eventNews in SummaryCloud DX chosen as…

2 years ago

World-First Scalp Cooling Summit Unites Industry Leaders to Discuss Future of Supportive Cancer Care

HOUSTON, TX / ACCESSWIRE / April 25, 2022 / The world's first Scalp Cooling Summit will unite global oncology and…

2 years ago

TRxADE HEALTH, INC. to Report First Quarter 2022 Financial Results on Monday, May 9th at 5:00 p.m. Eastern Time

TAMPA, FL / ACCESSWIRE / April 25, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused…

2 years ago

Aytu BioPharma Announces Positive Preclinical Data in Ventilator-Associated Pneumonia with its Novel, Proprietary Healight(TM) Delivery Technology

Preclinical Proof-of-Concept Study Demonstrates Effectiveness of Healight in Delaying Time to Development of Ventilator-Associated PneumoniaENGLEWOOD, CO / ACCESSWIRE / April…

2 years ago